CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference
February 27 2024 - 4:05PM
Business Wire
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a
leading precision medicine company focused on the discovery,
development, and commercialization of clinically differentiated,
high-value healthcare solutions for transplant patients and
caregivers – today announced that the company will be participating
in the upcoming Raymond James & Associates’ 45th Annual
Institutional Investors Conference.
CareDx’s management is scheduled to present on Wednesday, March
6, 2024, at 9:50 a.m. Eastern Standard Time. Interested parties may
access a live audio webcast by visiting the “Investors” section of
the company’s website at investors.CareDx.com.
About CareDx – The Transplant Company
CareDx, Inc., headquartered in Brisbane, California, is a
leading precision medicine solutions company focused on the
discovery, development, and commercialization of clinically
differentiated, high-value healthcare solutions for transplant
patients and caregivers. CareDx offers testing services, products,
and digital healthcare solutions along the pre- and post-transplant
patient journey and is the leading provider of genomics-based
information for transplant patients. For more information, please
visit www.CareDx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240227235923/en/
CareDx, Inc. Media Relations Anna Czene 818-731-2203
aczene@caredx.com
Investor Relations Greg Chodaczek investor@caredx.com
CareDx (NASDAQ:CDNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
CareDx (NASDAQ:CDNA)
Historical Stock Chart
From Apr 2023 to Apr 2024